Welcome to our dedicated page for Quad / Graphics SEC filings (Ticker: QUAD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quad/Graphics blends massive print operations with fast-growing marketing services, so its SEC filings track a business in transition. Whether you’re comparing press-room margins to data-driven revenue or monitoring restructuring costs, the details live inside each form—and they can run more than 250 pages.
Stock Titan’s platform turns that bulk into clarity. Our AI-powered summaries surface what matters in a Quad/Graphics annual report 10-K simplified, highlight segment revenue shifts in every Quad/Graphics quarterly earnings report 10-Q filing, and flag Quad/Graphics 8-K material events explained within minutes of hitting EDGAR. Want to follow leadership moves? Get Quad/Graphics Form 4 insider transactions real-time alerts and spot patterns in Quad/Graphics executive stock transactions Form 4 without manual digging.
Practical insights appear alongside each document: cash-flow trends for capital-intensive presses, progress on cost-out initiatives, and pension obligations that often hide deep in footnotes. You can also read our concise take on the Quad/Graphics proxy statement executive compensation to see how incentives align with the print-to-marketing pivot. From Quad/Graphics earnings report filing analysis to “Quad/Graphics SEC filings explained simply,” every question is answered. Start understanding Quad/Graphics SEC documents with AI—and make confident decisions faster.
Quad/Graphics, Inc. ("QUAD") filed a Form S-8 on 30 July 2025 to register 3,000,000 additional Class A shares under its 2020 Omnibus Incentive Plan. The new shares were approved by the Board before the 2025 Annual Meeting and received shareholder approval in May 2025. They supplement 6 million shares registered in 2020 and 2023, bringing the total pool available for equity awards to 9 million. The filing incorporates the earlier S-8 registrations by reference and includes standard exhibits, legal opinions and consents. No financial results or guidance are provided; the statement solely facilitates issuance of the newly authorized shares for employee and director compensation.
Quad/Graphics (Q2 25 10-Q): Net sales fell 9.8% YoY to $571.9 m as product sales declined 10% and services 9%. Gross profit slipped to $123.8 m (21.6% margin), yet tight cost control kept operating income at $13.7 m (2.4% margin, –9% YoY). Interest expense dropped 23% to $13.2 m, resulting in essentially breakeven EPS ($0.00 vs -$0.06). Six-month figures show a sharper turnaround: sales –6.8% to $1.20 bn but operating income up 7.5× to $33.3 m; net earnings swung to $5.7 m profit (EPS $0.12) from a $30.9 m loss.
Liquidity & leverage: Cash fell to $6.7 m (vs $29.2 m YE) after -$41.6 m operating cash outflow and $38.2 m investing spend, including $27 m for Enru assets. Long-term debt rose to $420.5 m, but total liabilities declined 7.6% to $1.15 bn; equity improved to $87.0 m on OCI gains. Revolver usage remains active; leverage covenants were amended in Oct-24.
Strategic moves: 1) Acquired Enru co-mail assets to expand logistics platform. 2) Divested European operations for $24.1 m (note receivable) with a $0.5 m loss, lowering international exposure. 3) Restructuring/impairment charges dropped to $15.8 m YTD (-63%), supporting margin recovery. Capital returns resumed: $7.6 m buybacks & $0.075/sh quarterly dividend.
On 29 Jul 2025, Larimar Therapeutics (LRMR) furnished a Form 8-K (Item 2.02) to disclose preliminary liquidity for the quarter ended 30 Jun 2025. Management estimates $138.5 million in cash, cash equivalents and marketable securities at that date.
The amount is unaudited and subject to change pending completion of the Q2 closing and review process. No additional operating results, balance-sheet details, or forward guidance were included. The same figure appears in a preliminary prospectus supplement filed under Rule 424(b)(5). Because the data are “furnished” rather than “filed,” they are not subject to Exchange Act Section 18 liability.